Omega-3 Index (Omega-3 Index)
The Omega-3 Index test determines the content of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in blood - key components of omega-3 polyunsaturated fatty acids. The study reflects the state of the cardiovascular system, level of systemic inflammation, and risk of atherosclerosis, and allows assessment of adequacy of omega-3 consumption from food or supplements.
Biomaterial: Venous blood
- Draw blood fasting
- Exclude fatty food and alcohol 24 hours before
Medications:
If possible, discontinue omega-3 preparations and fish oil 24-48 hours before
If discontinuation is not possible - indicate at time of testing
- Elevated cardiovascular disease risk
- Arterial hypertension
- Atherosclerosis and lipid metabolism disorders
- Metabolic syndrome
- Chronic inflammatory conditions
- Monitoring omega-3 supplement efficacy
- Diet quality assessment
Recommended for patients with heart/vascular diseases, excess body weight, elevated cholesterol, patients taking omega-3 supplements, persons with low fish/seafood consumption
Low Omega-3 Index - insufficient EPA and DHA intake - elevated cardiovascular risk - reduced anti-inflammatory protection
Optimal level - adequate cardiovascular protection - favorable anti-inflammatory balance
High level - usually associated with regular omega-3 intake - generally no clinically significant harmful effects
